Prostate Cancer Screening
Humana Press Inc.
978-0-89603-901-8 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In "Prostate Cancer Screening, Second Edition", the world's leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world's experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer.An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, "Prostate Cancer Screening, Second Edition", is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
Epidemiology of Prostate Cancer, Wael A. Sakr and Clara Ward. Natural History of Prostate Cancer, Peter C. Albertsen. Mathematical Issues: PSA Testing, Ruth Etzioni and David F. Penson. Evidence of Benefit of Screening in Other Cancers, Ismail Jatoi. The Role of Prostate Specific Antigen and Its Variants in Prostate Cancer Screening, Faiyaaz M. Jhaveri, Michael K. Brawer, and Eric A. Klein. The Digital Rectal Examination in Prostate Cancer Screening, Joseph Basler. Philosophical Reflections on PSA Screening: What Should We Now Think and Do? Paul H. Lange. Imaging in Prostate Cancer Screening, Aaron Sulman and Martin I. Resnick. Risk Factors for Prostate Cancer, David L. Shepherd. Transrectal Ultrasound and Artifical Neural Networks in the Diagnosis of Prostate Cancer, Tillmann Loch. Evidence of the Effectiveness of Prostate Cancer Screening, Chris Magee and Ian M. Thompson. Prostate Cancer Screening: A Note of Caution, Otis W. Brawley. Quality of Life and Health Behavior in Prostate Cancer Screening Populations, Mark S. Litwin and Kristen A. Reid. Prostate Cancer Screening Recommendations from Organized Medicine, Gregory T. Sweat. Informed Consent and Prostate Specific Antigen Screening: What Patients Ought to Know, Evelyn C. Y. Chan. Experience of Prostate Cancer Awareness Week, Zinelabidine Abouelfadel and E. David Crawford. The Laval University Screening Trial Results, Fernand Labrie, Bernard Candas, Lionel Cusan, and Jose-Luis Gomez. Cancer of the Prostate Risk Index Test and Software (CAPRI), Scott A. Optenberg, Atanacio C. Guillen, John P. Campbell, and Ian M. Thompson. The European Randomized Study of Screening for Prostate Cancer (ERSPC), Fritz H. Schroder and Ingrid van der Cruijsen-Koeter for the ERSPC Study Group. Index.
| Erscheint lt. Verlag | 1.6.2001 |
|---|---|
| Reihe/Serie | Current Clinical Urology |
| Zusatzinfo | 58 black & white illustrations, 18 black & white halftones, 40 black & white line drawings |
| Verlagsort | Totowa, NJ |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Gewicht | 658 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
| Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
| ISBN-10 | 0-89603-901-3 / 0896039013 |
| ISBN-13 | 978-0-89603-901-8 / 9780896039018 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
